Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Bicara Therapeutics Inc. | Chief Executive Officer, Director | Common Stock | 310K | $5.83M | $18.83 | Oct 16, 2025 | Direct |
Relay Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 421K | Jun 9, 2025 | Direct | ||
Bicara Therapeutics Inc. | Chief Executive Officer, Director | Stock Option (Right to Buy) | 277K | Oct 16, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BCAX | Bicara Therapeutics Inc. | Oct 16, 2025 | 3 | -$362K | 4 | Oct 20, 2025 | Chief Executive Officer, Director |
BCAX | Bicara Therapeutics Inc. | Oct 13, 2025 | 6 | -$373K | 4 | Oct 15, 2025 | Chief Executive Officer, Director |
RLAY | Relay Therapeutics, Inc. | Jun 9, 2025 | 1 | $0 | 4 | Jun 11, 2025 | Director |
RLAY | Relay Therapeutics, Inc. | Jun 9, 2025 | 0 | $0 | 3 | Jun 11, 2025 | Director |
BCAX | Bicara Therapeutics Inc. | Sep 12, 2024 | 0 | $0 | 3 | Sep 12, 2024 | Chief Executive Officer, Director |